Clinical trial
A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder…
NCT00231790 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00231790 |
|---|---|
| Title | A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007) |
| Official title | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of MK0634 in Postmenopausal Women With Overactive Bladder |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Urinary Incontinence |
| Intervention type | Drug |
| Interventions | MK-0634 50 mg, MK-0634 125 mg, Placebo for MK-0634 |
| Enrollment | 848 |
| Start date | Aug 1, 2005 |
| Primary completion | Sep 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Oct 4, 2005 |
| Last update posted | Dec 17, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: